AmerisourceBergen Corporation (ABG MU) stock market data APIs
€286.5458
0(0%)
as of October 24, 2025
Try our APIs with
free plan!
AmerisourceBergen Corporation Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for ABG.MU.
Prev. Close
286.5458
Open
286.5458
High
286.5458
Low
286.5458
52 wk Range
210.3026-284.35
Market Cap
22 692 M
Dividends (Yield)
0.0154
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get AmerisourceBergen Corporation data using free add-ons & libraries
Get AmerisourceBergen Corporation Fundamental Data
AmerisourceBergen Corporation Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
AmerisourceBergen Corporation News
New
Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings
Cardinal Health, Inc. CAH is scheduled to report first-quarter fiscal 2026 results on Oct. 30, before market open. In the last reported quarter, the company’s adjusted earnings per share (EPS) of $...
Universal Health to Report Q3 Earnings: Key Estimates to Note
Universal Health Services, Inc. UHS is set to report third-quarter 2025 results on Oct. 27, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currentl...
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Cencora (COR), which belongs to the Zacks Medical...
How McKesson’s (MCK) Exclusive PHYRAGO Distribution Could Shape Its Specialty Pharma Growth Trajectory
Earlier this week, Cycle Pharmaceuticals announced the launch of PHYRAGO, a new oncology therapy for leukemia, developed with Handa Therapeutics and made exclusively available in the US through Onco36...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
